Loading...
This year, our list of the top 10 Journal Watch Oncology and Hematology stories covers a broad range of topics, including benign and malignant hematology and cancers of the breast, prostate, and gastrointestinal tract. These summaries illustrate our goal of identifying the most clinically relevant journal articles and highlighting their key points, limitations, and implications.
Our top stories for 2012 are:
T-DM1 Prolongs Survival in Advanced HER2-Positive Breast Cancer
Second-Generation Antiandrogen for Advanced Prostate Cancer
Intermittent vs. Continuous Androgen Deprivation Therapy for Nonmetastatic Prostate Cancer
Radical Prostatectomy vs. Observation for Early-Stage Prostate Cancer
Preoperative Chemoradiotherapy Improves Survival in Esophageal Cancer
Longer Imatinib Therapy Effective for Gastrointestinal Stromal Tumors
Tumor Heterogeneity Challenges Targeted Therapy
Maintenance Lenalidomide for Multiple Myeloma
Ruxolitinib Effective for Myelofibrosis
Preventing Thrombosis During Chemotherapy
All best wishes for the New Year,